CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas.

Détails

Ressource 1Télécharger: 5_26747248_Postprint.pdf (7281.99 [Ko])
Etat: Public
Version: Author's accepted manuscript
ID Serval
serval:BIB_52D653869A41
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas.
Périodique
Blood
Auteur(s)
Juilland M., Gonzalez M., Erdmann T., Banz Y., Jevnikar Z., Hailfinger S., Tzankov A., Grau M., Lenz G., Novak U., Thome M.
ISSN
1528-0020 (Electronic)
ISSN-L
0006-4971
Statut éditorial
Publié
Date de publication
2016
Peer-reviewed
Oui
Volume
127
Numéro
14
Pages
1780-1789
Langue
anglais
Résumé
A hallmark of the diffuse large B-cell lymphoma (DLBCL) of the activated B-cell (ABC) type, a molecular subtype characterized by adverse outcome, is constitutive activation of the transcription factor nuclear factor-κB (NF-κB), which controls expression of genes promoting cellular survival and proliferation. Much less, however, is known about the role of the transcription factor activator protein-1 (AP-1) in ABC DLBCL. Here, we show that AP-1, like NF-κB, was controlled by constitutive activation of the B-cell receptor signaling component caspase recruitment domain-containing membrane-associated guanylate kinase 1 (CARMA1) and/or the Toll-like receptor signaling component myeloid differentiation primary response gene 88 (MyD88) in ABC DLBCL cell lines. In contrast to germinal center (GC) B-cell (GCB) DLBCL, ABC DLBCL cell lines expressed high levels of the AP-1 family members c-Jun, JunB, and JunD, which formed heterodimeric complexes with the AP-1 family members activating transcription factor (ATF) 2, ATF3, and ATF7. Inhibition of these complexes by a dominant-negative approach led to impaired growth of a majority of ABC DLBCL cell lines. Individual silencing of c-Jun, ATF2, or ATF3 decreased cellular survival and revealed c-Jun/ATF2-dependent control of ATF3 expression. As a consequence, ATF3 expression was much higher in ABC vs GCB DLBCL cell lines. Samples derived from DLBCL patients showed a clear trend toward high and nuclear ATF3 expression in nodal DLBCL of the non-GC or ABC subtype. These findings identify the activation of AP-1 complexes of the Jun/ATF-type as an important element controlling the growth of ABC DLBCL.
Mots-clé
Activating Transcription Factor 2/genetics, Activating Transcription Factor 2/metabolism, Activating Transcription Factor 3/genetics, Activating Transcription Factor 3/metabolism, Activating Transcription Factors/genetics, Activating Transcription Factors/metabolism, CARD Signaling Adaptor Proteins/genetics, CARD Signaling Adaptor Proteins/metabolism, Gene Expression Regulation, Neoplastic, Germinal Center/metabolism, Germinal Center/pathology, Guanylate Cyclase/genetics, Guanylate Cyclase/metabolism, Humans, Jurkat Cells, Lymphoma, Large B-Cell, Diffuse/genetics, Lymphoma, Large B-Cell, Diffuse/metabolism, Myeloid Differentiation Factor 88/genetics, Myeloid Differentiation Factor 88/metabolism, Proto-Oncogene Proteins c-jun/genetics, Proto-Oncogene Proteins c-jun/metabolism, Transcription Factor AP-1/genetics, Transcription Factor AP-1/metabolism, Transcription Factors/genetics, Transcription Factors/metabolism
Pubmed
Web of science
Création de la notice
02/02/2016 13:35
Dernière modification de la notice
20/08/2019 14:08
Données d'usage